Pharmaceuticals

Alchemie Shanghai possesses world-class expertise in distribution of several basic chemicals, agrochemicals, specialty chemicals, and intermediates for pharmaceuticals and agrochemicals.

As part of its key business, the manufacturing unit at Aarti Industries focuses on:

  • Active Pharmaceutical Ingredients
  • Custom Synthesis & Contract Research
API manufacturing division

Our active pharmaceutical ingredients manufacturing facility is USFDA & EUGMP which are accredited with dedicated production blocks for Steroids and Oncological APIs.

One of the reasons why we sustain our leadership position is because of backward integration. Manufacturing of the key raw materials for its strongest products is the core strength of the API business which enables Alchemie Shanghai to sustain its leadership position.

We have some dedicated, world class manufacturing facilities for Xanthine derivatives with a mammoth capacity for its flagship product, Caffeine (3600 Mt capacity per annum).

We are also the preferred partner in the regulated markets since we provide Regulatory Documentation & IPR support for global markets (17 CEPs & 26 USDMFs).

Aarti Intermediates
and Contract Research division

Aarti Intermediates and Contract Research division has emphasis on tailored process development, scale-up and exclusive manufacturing. These services are provided under strict Intellectual Property Protection guarded by confidentiality agreements with our clients.

The goal is to provide reliable and strong platform to our customers, enabling them to accelerate their NCE &API's development program, efficiently and cost effectively.

Manufacturing Units

Aarti Industries has 6 manufacturing units including RnD centers mostly located in close proximity to the large ports of western India.

Unit 1
Dombivali

The facility is aligned with R & D of Autoclave, Flow reactors, RBF & other equipment capability of approximately 234 Lit.

The R & D facility has Human Resource strength of 44 dedicated employees.

Unit 2
Vapi | Custom Synthesis Division

The site has four manufacturing blocks aligned with more than 75 reactors (SS reactors, GLR reactors, hydrogenetor) with a combined capacity of 329000 liters, engaged in manufacturing of Intermediates require for the manufacture of Active Pharmaceutical Ingredients.

The site has the strength of 350 well-trained personnel for ensuring adherence to quality systems and procedures.

Unit 3
Tarapur

Specializes in the manufacture of Xanthine derivatives including Caffeine, Theophylline, Etofylline, and Aminophylline.

The facility is aligned with SS reactors, GLR reactors & PP reactors with an API manufacturing capability of approximately 300 metric tonne per month.

The facility has Human Resource strength of 136 dedicated employees.

Unit 4
Tarapur

Manufacturing Blocks which specialize in the manufacture of General APIs, Steroids and Anticancer APIs

  • Manufacturing Block No. – 1: General API
  • Manufacturing Block No. – 2: Steroids API (Dedicated)
  • Manufacturing Block No. – 3: Anticancer API (Dedicated)
  • Manufacturing Block No. – 4: General API

These blocks in the facility are aligned with more than 50 reactors (SS reactors, GLR reactors & PVDF reactors) with a combined capacity of 102,500L.

The facility has Human Resource strength of 345 dedicated employees.

Unit 5
Tarapur

Specializes in the manufacture of General API.

The facility is aligned with SS reactors with a total capacity of 50,500L.

The facility has Human Resource strength of 47 dedicated employees.

This unit is Capable of handling Methylation reaction.

RnD
Dombivali

Specializes in the manufacture of Active Pharmaceutical Ingredients.

The facility is aligned with SS reactors, GLR reactors, hydrogenator & PP reactors with an API manufacturing capability of reactor is approximately 31,510L.

The facility of Manufacturing has Human Resource strength of 171 dedicated employees.